Back
Day Range
$75.50
$80.32
52-Week Range
$13.37
$88.02
Volume
1,134,309
50D / 200D Avg
$56.34
/
$37.05
Prev Close
$77.76
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -17.7 | 0.4 |
| P/B | 5.8 | 2.9 |
| ROE % | -38.4 | 3.8 |
| Net Margin % | -7973.3 | 3.9 |
| Rev Growth 5Y % | 8.4 | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$101.00
+27.3%
Low: $55.00
High: $145.00
Forward EPS
-$4.30
Est. Revenue
1.5 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$2.60
-$0.25 – $10.68
|
670 M | 4 |
| FY2029 |
-$3.70
-$15.21 – $0.36
|
200 M | 4 |
| FY2028 |
-$5.47
-$8.72 – -$3.31
|
19 M | 11 |
Key Takeaways
Revenue grew 8.37% annually over 5 years — modest growth
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -129.27M
Revenue growth is decelerating — 1Y growth trails 5Y average by 75.72%
Growth
Revenue Growth (5Y)
8.37%
Revenue (1Y)-67.35%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-38.38%
ROIC-26.97%
Net Margin-7973.33%
Op. Margin-8739.34%
Safety
Debt / Equity
0.00
Current Ratio13.32
Interest Coverage0.00
Valuation
P/E Ratio
-17.69
P/B Ratio5.82
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -67.35% | Revenue Growth (3Y) | -15.12% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 8.37% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.04M | Net Income (TTM) | -162.34M |
| ROE | -38.38% | ROA | -30.58% |
| Gross Margin | 100.00% | Operating Margin | -8739.34% |
| Net Margin | -7973.33% | Free Cash Flow (TTM) | -129.27M |
| ROIC | -26.97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 13.32 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -17.69 | P/B Ratio | 5.82 |
| P/S Ratio | 1410.76 | PEG Ratio | -0.15 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.87B | Enterprise Value | 2.82B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.04M | 6.24M | 2.83M | 6.42M | 1.48M |
| Net Income | -162.34M | -84.97M | -43.56M | -28.48M | -13.11M |
| EPS (Diluted) | -4.20 | -2.55 | -8.45 | -7.60 | -3.82 |
| Gross Profit | 2.04M | 6.24M | 2.83M | 6.42M | 1.48M |
| Operating Income | -177.93M | -101.86M | -48.17M | -29.71M | -13.09M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 530.92M | 374.01M | 179.41M | 83.11M | 189.93M |
| Total Liabilities | 37.52M | 21.53M | 10.54M | 9.45M | 17.26M |
| Shareholders' Equity | 493.40M | 352.48M | 168.87M | 73.66M | 172.67M |
| Total Debt | 1.39M | 1.49M | 585,000.0 | 788,000.0 | 0.0 |
| Cash & Equivalents | 51.09M | 22.79M | 132.33M | 15.37M | 131.65M |
| Current Assets | 409.44M | 280.90M | 177.45M | 82.03M | 180.69M |
| Current Liabilities | 30.73M | 18.45M | 9.63M | 8.23M | 10.86M |